Managed Account Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$11K Buy
440
+21
+5% +$477 ﹤0.01% 2868
2015
Q1
$8K Buy
+419
New +$7.38K ﹤0.01% 2840
2014
Q4
Sell
-2,460
Closed -$32K 2763
2014
Q3
$32K Sell
2,460
-383
-13% -$5.78K ﹤0.01% 2470
2014
Q2
$57K Sell
2,843
-616
-18% -$9.12K ﹤0.01% 2388
2014
Q1
$66K Buy
3,459
+114
+3% +$2.17K ﹤0.01% 2341
2013
Q4
$57K Sell
3,345
-221
-6% -$3.38K ﹤0.01% 2345
2013
Q3
$56K Buy
+3,566
New +$45.3K ﹤0.01% 2270

Other funds holding INSM

Managed Account Advisors's INSM Position: Q2 2015 in Review

Managed Account Advisors increased its Insmed (INSM) stake by 5% in Q2 2015, buying an estimated $477 and bringing the position to 440 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #2868.

Managed Account Advisors first reported a position in INSM in Q3 2013 and has held it in 7 quarters since. The position peaked at $66K in Q1 2014. 116 funds tracked by Wall St. Rank hold INSM as of Q2 2015.

  • Managed Account Advisors held 440 shares of Insmed worth $11K as of Q2 2015.
  • Managed Account Advisors bought 21 Insmed shares in Q2 2015, an estimated $477.
  • Insmed made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2868 holding.
  • Managed Account Advisors first reported a position in Insmed in Q3 2013 and has held it in 7 quarters since.
  • Managed Account Advisors's Insmed position peaked at $66K in Q1 2014.
  • 116 funds tracked by Wall St. Rank held Insmed as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.